Dopamine-mediated effects induced by metoclopramide simultaneously on adrenocorticotropic hormone and prolactin in patients with pituitary and/or hypothalamic disorders.
Nishida
S
S
Department of Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Matsuki
M
M
Horino
M
M
Kawai
Y
Y
Tsushima
K
K
Yoneda
M
M
Oyama
H
H
Ishii
R
R
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000378:metabolism*; D000328:Adult; D000368:Aged; D002648:Child; D004298:Dopamine / Q000502:physiology*; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000378:metabolism; D007027:Hypothalamic Diseases / Q000503:physiopathology*; D007328:Insulin; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology*; D008875:Middle Aged; D010900:Pituitary Diseases / Q000503:physiopathology*; D011388:Prolactin / Q000097:blood / Q000378:metabolism*
D007328:Insulin; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013006:Growth Hormone; D008787:Metoclopramide; D004298:Dopamine; D006854:Hydrocortisone